As an organization that has been funding HIV/AIDS research since 1995, we at The Campbell Foundation know the harsh realities of successes and failures in the lab. It can be a one-step forward, two steps back process.
So, when a researcher we fund makes important and newsworthy headlines, we are always excited to be a part of it.
This week, Dr. Susana Valente, a researcher with The Scripps Research Institute in Florida, along with her colleagues, have shown for the first time that a novel compound effectively suppresses the production of the HIV virus in chronically infected cells and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation. The study was published in Cell Reports.
Last year, The Campbell Foundation awarded a $79,151 grant to Dr. Valente to conduct this novel and groundbreaking research.
When donors give to The Campbell Foundation, they do so with the hope that one day there will be a cure for HIV/AIDS. Valente’s research is another step in that direction and we are happy to have played a part.
You can read more about the study by clicking here.